House Republicans advanced a bill on Tuesday that critics are denouncing as a “book ban bill” and a “don’t say trans” bill, but Republicans say it is necessary to prevent schools from hiring strippers ...

Nothing in America compares to short-track racing. From a bullring in Riverhead, New York to the Grandview dirt in Pennsylvania and the Hawkeye Downs plains in Iowa, every NASCAR Advance Auto Parts ...

The Hacker News is the top cybersecurity news platform, delivering real-time updates, threat intelligence, data breach reports, expert analysis, and actionable insights for infosec professionals and ...

NEW ORLEANS – Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced cancer treatment, as the first institution in Louisiana to ...

VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved therapeutic assets, today announced a ...

Patients in East Texas now have access to a new, advanced form of heart-imaging technology that physicians say can provide clearer, more accurate evaluations of blood flow to the heart and help detect ...

OpenAI CEO and Stanford dropout Sam Altman returned to campus Saturday evening to speak at the opening ceremony of TreeHacks, Stanford’s annual student-run hackathon. Addressing a packed audience of ...

Rei Penber is the Deputy Lead Editor for GameRant's Anime and Manga team, originally from Kashmir and currently based in Beirut. He brings seven years of professional experience as a writer and editor ...

Boston University researchers in a groundbreaking study found that those with CTE have a much higher chance of being diagnosed with dementia. The largest study of its kind from the Boston University ...

Kids and families filled Empire State Plaza on today as the Capital Region’s children took over the convention center for this year’s Kids Expo.MORE:Albany PAL Albany PAL gives kids a March ...

Pfizer Inc.’s Tukysa, when given as part of the initial treatment for an advanced form of breast cancer, delayed tumor growth by more than eight months, according to a study that may expand its use.